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Abstract Fanconi anemia (FA) is an autosomal recessive
disorder characterized by skeletal abnormalities, pancytopenia
and a marked predisposition to cancer. FA cells exhibit
chromosomal instability and hypersensitivity towards oxygen
and cross-linking agents such as diepoxybutane and mitomycin
C. An increased level of reactive oxygen intermediates and an
elevation of 8-oxoguanine in FA cells point to a defective oxygen
metabolism in FA cells. We investigated the repair activity of
oxidatively damaged DNA in lymphoblastoid cells from FA
patients of complementation groups A^E. The repair activity for
oxidatively damaged DNA was significantly reduced in lympho-
blastoid cell lines of complementation groups B^E. Complemen-
tation of the FA-C cell line with the wild type FA-C gene restored
the repair activity to normal. This indicates that the FA-C
protein participates in the repair of oxidatively damaged DNA.
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1. Introduction
Fanconi anemia (FA) is an autosomal recessive disorder
characterized by progressive pancytopenia, hyperpigmentation
of the skin and multiple congenital abnormalities [1,2]. In
addition, FA patients have a considerably increased risk of
developing cancer, mainly acute myeloid leukemia and squa-
mous cell carcinoma. FA cells exhibit an increased rate of
spontaneous chromosomal breaks and show hypersensitivity
to cross-linking agents such as mitomycin C, diepoxybutane
and cisplatin as well as hypersensitivity towards oxygen [3^5].
These features suggested a molecular defect in the DNA re-
pair system of FA patients [6^10], detection of which has led
to results which are discussed ambiguously [11^14].
Genes have been cloned for the complementation groups
FA-A and FA-C [15,16]. No homologies to other genes
have been found and the functions of the resultant proteins,
probably of cytoplasmic origin, are unknown [17,18]. Re-
cently, an increased level of reactive oxygen intermediates
(ROI) [19] and an increased level of 8-hydroxy-2P-deoxygua-
nosine in FA cells have been reported [20,21], both of which
could potentially generate oxidatively damaged DNA. Whilst
overproduction of ROI and oxygen and mitomycin C hyper-
sensitivity may be due to defective redox cycling [14,22], chro-
mosomal instability indicates improper handling of damaged
DNA.
We investigated the capacity of FA cells to repair oxida-
tively damaged DNA. We made use of the chloramphenicol
acetyltransferase (CAT) assay [23] and generated oxidative
DNA damage in vitro with the aid of potassium permanga-
nate, which creates a broad spectrum of oxidative DNA le-
sions.
2. Materials and methods
2.1. Chemicals
Chemicals were purchased from Sigma, Roth or Merck unless oth-
erwise indicated. [14C]Chloramphenicol was purchased from ICN.
2.2. Plasmids
For CAT experiments the pCATcontrol (Promega) and pcDNA3CAT
(Invitrogen) plasmids were used.
2.3. Cell lines and culture conditions
The lymphoblastoid cells used in this study (Table 1) were cultured
in RPMI 1640 medium (Biochrom, Berlin) containing 10% fetal calf
serum (Biochrom, Berlin). All cells were cultured at 37‡C under an
atmosphere of 5% CO2 in air. The stably transfected cells were grown
in the same medium supplemented with hygromycin (¢nal concentra-
tion, 200 Wg/ml; Boehringer Mannheim, Germany).
2.4. Transient transfections
Lymphoblastoid cells were transfected by electroporation. Brie£y,
cells were washed with 1UHeBS bu¡er (20 mmol/l HEPES, pH 7.1;
137 mmol/l NaCl; 5 mmol KCl; 0.7 mmol Na2HPO4W2H2O; 6 mmol/l
D-glucose), resuspended in 1UHeBS bu¡er to a cell density of 2^
4U106 cells/50 Wl, transferred to a 4-mm cuvette containing 10 Wg
plasmid (damaged or undamaged) and incubated for 10 min at
room temperature. The volume was adjusted to 100 Wl with 1UHeBS.
Electroporation was performed using the Bio-Rad Gene Pulser (Bio-
Rad Laboratories, CA) with a pulse-setting at 250 V/200 6/250 WFd.
After 10 min at room temperature cells were resuspended in RPMI
1640 supplemented with 15% fetal calf serum and antibiotics. 48 h
after transfection, cells were used for CAT assays.
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Table 1
Lymphoblastoid cell lines used in the experiments
Cell line Genotype/phenotype
HSC92 Wild type
HSC72 FA-A
HSC230 FA-B
HSC536 FA-C
HSC536pDR FA-C, stably transfected with the empty vector
HSC536pDR/FA-C FA-C, stably transfected with the wild type
FA-C gene
HSC62 FA-D
VU130L FA-E
All lymphoblastoid cells were donated by H. Joenje, Amsterdam.
*Corresponding author. Fax: (49) (30) 838 6509.
E-mail: wrupp@chemie.fu-berlin.de
1Present adress: Department of Applied Toxicology, University
Mainz, Obere Zahlbacher StraMe 67, D-55131 Mainz, Germany.
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2.5. CAT assay
CAT assays were performed as described [22]. Brie£y, transfected
cells were harvested after 48 h, resuspended in 0.3 mol/l Tris-HCl, pH
7.0 and lysed by three times freezing and thawing. 50 Wl of the lysate
were incubated with 25 Wl CAT mix (4 mg/ml acetyl coenzyme A,
1 WCi [14C]chloramphenicol) for 4 h at 56‡C. Chloramphenicol and
acetylated derivatives were extracted with 0.9 ml ethyl acetate. After
evaporation of the ethyl acetate the products were separated by thin
layer chromatography on silica gel sheets (Kieselgel 60 F254, Merck,
Darmstadt, Germany) with chloroform/methanol (95/5) as solvent.
Spots were either identi¢ed by autoradiography, cut out and counted
by liquid scintillation, or they were quanti¢ed by means of the Fuji-
¢lm BAS-1500 Phosphoimager.
2.6. Oxidative damage of plasmid DNA
0.02^0.04 Wg/Wl CAT plasmid solutions were treated with 0^3 mM
potassium permanganate for exactly 2 min at room temperature. Plas-
mids were precipitated with ethanol/sodium acetate and placed on ice
immediately after treatment. Resulting MnO2 was completely re-
moved by precipitation and washing with 70% ethanol for several
times.
3. Results
To investigate the repair capacity of cells from FA patients
and una¡ected controls, we chose a set of well de¢ned lym-
phoblastoid cells and transfected them with extracellularly
oxidatively damaged CAT plasmid DNA. As damaging agent
we used potassium permanganate (KMnO4) to create oxida-
tive DNA injuries [24^26]. The CAT plasmid carries the bac-
terial gene for chloramphenicol acetyltransferase behind the
eukaryotic SV40 promoter. CAT activity, determined in cell
extracts, depends on the amount of damage and the repair
capacity of the tested cells. The result for each sample repre-
sents the percentage of conversion of chloramphenicol to its
acetylated derivatives, related to the CAT activity of cells
transfected with untreated plasmid. To determine the state
of KMnO4 treated plasmid DNA, the plasmids were analyzed
by agarose gel electrophoresis (Fig. 1a,b). A KMnO4 concen-
tration of more than 2.5 mM led to strand breaks as visible by
the reduction of the supercoiled form (Fig. 1a). KMnO4 con-
centrations of more than 25 mM resulted in the total destruc-
tion of plasmid DNA (Fig. 1b). Because of these results the
plasmid DNA used for the CAT experiments was treated with
less than 5 mM KMnO4.
Fig. 2 shows CAT reactivation curves for FA cells of com-
plementation groups A^E in comparison to a normal control
cell. With the exception of strain HSC72 (FA-A), all FA lym-
phoblastoid cells (FA-B^E) revealed a considerably less e⁄-
cient repair of oxidative DNA damages than did the healthy
control cells (Fig. 2). The FA-A cell line (HSC72) repaired the
CAT plasmid more e⁄ciently than did the healthy control
cells.
To explore whether the repair de¢ciency manifested in lym-
phoblastoid cells re£ected an inborn feature of FA, repair
activity for oxidatively damaged CAT plasmid was measured
in the FA-C cell line HSC536 that had been stably transfected
with the wild type FA-C gene. Indeed, the complemented
HSC536 cell line exhibited an almost normal repair capacity.
Transfection of the empty vector, however, had no bene¢cial
e¡ect on DNA repair (Fig. 3). This experiment clearly dem-
onstrated the involvement of FA-C in a distinct cellular proc-
ess.
4. Discussion
Increased amounts of ROI and high oxygen sensitivity are
exerted by FA cells. Consequent oxidative damage to DNA
and insu⁄cient DNA repair might result, which may be re-
sponsible for the elevated level of 8-oxoguanine and chromo-
somal instability characteristic of FA cells.
In previous experiments it was shown that the CAT-based
assay is a powerful tool to analyze DNA repair of human cells
[12,14,23]. Using the CAT assay procedure, we analyzed oxi-
dative DNA damage repair in cells of FA patients and in a
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Fig. 1. Analysis of KMnO4 damaged plasmid DNA on 1% agarose
gel. I, relaxed form; II, linearized form; III, supercoiled form. a: 0^
10 mM KMnO4. b: 10^100 mM KMnO4. The plasmid DNA was
treated as described in Section 2. Equal amounts of plasmid DNA
were applied in each lane.
Fig. 2. Reactivation of KMnO4 damaged CAT plasmid by lympho-
blastoid cells. The vector pcDNA3 CAT was damaged with various
concentrations of KMnO4. The result for each sample represents
the percentage of conversion of chloramphenicol to its acetylated
derivatives, related to the CAT activity of cells transfected with the
untreated plasmid. b, HSC92 (control); W, HSC72 (FA-A); O,
HSC230 (FA-B); a, HSC 536 (FA-C); U, HSC62 (FA-D); E,
VU130L (FA-E).
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healthy control. A decreased repair e⁄ciency became evident
in all lymphoblastoid FA cell lines except FA-A (Fig. 2).
That this oxidative DNA damage repair de¢ciency is di-
rectly related to the basic molecular defect of FA could be
shown for FA-C, one of the two FA complementation groups
with a cloned gene defect. Expression of FA-C protein in FA-
C lymphoblastoid cells by stable transfection of the wild type
FA-C cDNA normalized the repair capacity of this cell line
(Fig. 3) and disclosed the involvement of the FA-C protein in
repair processes of oxidatively damaged DNA. Unrepaired
DNA lesions signal delay to the cell cycle. The recently pub-
lished involvement of the FA-C protein in a pathway that
signals to the cyclin B/cdc2 kinase [27] may be operative in
this signal delay. Since FA-C is localized to the cytoplasm
[17,18] and binds to a number of cytosolic proteins [28], the
protein may be a member of a multifunctional complex that
triggers redox-dependent cellular functions not only in the
cytoplasm but also in the nucleus. Recently, the FA-C and
FA-A proteins have been shown to form a complex that is
also found in the nucleus [29]. Thus, uncoupled FA-A and
FA-C may protect the cell against cytosolic ROI overproduc-
tion. In order to regulate ROI concentration in the nucleus
and to repair ROI damaged DNA, FA-C binds to FA-A, and
the complex is ¢nally translocated to the nucleus via the nu-
clear localization signal of the FA-A protein. There the com-
plex may combine probably with additional FA proteins, to
form an active repair complex.
The fact that in our experiments the FA-A lymphoblastoid
cell line (HSC72) displayed an excess of oxidative DNA dam-
age repair capability is of special interest. Explanations might
be: the defective FA-A protein is not able to protect the cell
against cytosolic ROI overproduction (see above). An in-
creased ROI level results ([19], own unpublished results) that
would lead to an increase in oxidative DNA lesions. FA-C not
e⁄ciently transported by the defective FA-A becomes super-
induced and binds to transport proteins with lower binding
a⁄nity than FA-A. Subsequently, most potent DNA repair
results in FA-A cells as demonstrated by our experiments.
Alternatively, the FA-A protein may serve special functions
in unravelling eukaryotic chromatin not required for CAT
plasmid. Third, the e¡ect could be unique to the special cell
line HSC72.
The existence of at least eight FA genes [30] and the fact of
a reduced repair capacity of oxidatively damaged DNA in
complementation groups B^E indicate that the FA proteins
function in a complex molecular pathway or are part of a
multiprotein complex that is involved in ROI detoxi¢cation,
DNA repair or maintenance of DNA stability.
For the complementation groups B, D and E the defective
genes have not yet been cloned. A likely possibility for a FA
defect might be a mutation in an enzyme specialized for oxi-
dized DNA repair. Thus, further investigations on DNA re-
pair enzymes that remove oxidative lesions from DNA in
these complementation groups are of great interest.
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